dr bharat patel - the new nhs
TRANSCRIPT
April 12, 2023
The new NHS and implications for microbiology laboratories
Friday 10 November 2006
Dr Bharat Patel
HPA London
Centre for Infections
Wilson Lecture Theatre
Colindale
Topics in Microbiology Management
BSMT National Conference
The NHS Plan
More & Better paid staff
Reduce waiting times
Improvements in local hospitals and surgeries
Extra Beds, doctors, nurses, hospitals etc
New system of earned autonomy
National Standards & regular inspections eg CHI
National Institute for Clinical Excellence
Modernisation Agency spreading best practice
Freedom to run own affairs
Social Services & NHS come together
Modern contract for GPs and Consultants
Nurses & others to extend roles
Patients have a real say
Private providers concordat
July 2000
27 July 2000
The New NHS
Department of Health
Support delivery
4 New Directors of Health and Social Care
replaces Regional Offices
Strategic Health Authorities
30 SHA – role strategic development & performance manage
Primary Care Trusts
Assess need, plan, secure health service & improve health
Acute Hospital Trusts
Provide service
July 2001
• Empowering frontline staff & Empowering patients
• Changing the culture & structure of the NHSJuly 2001
Health Protection Strategy
Protecting Public Health
Surveillance
Control communicable disease
Handling chemical incidents
Environmental hazards
Communicable disease law review
Community Infection Control
Robust chemical incident control
Emergency Planning
February 2001
Strengthening Health Protection
Chapter 10
Getting ahead of the curve – A strategy for infectious diseases ( including other aspects of health protection) CMO Jan 2002
Key Priorities
New & emerging infections
Tuberculosis
Health care associated infections
Antimicrobial resistance
Infectious diseases in children
Blood-borne & sexually transmitted viruses
Chronic diseases
New vaccines
Terrorism10th January 2002
Creating a patient-led NHS, delivering the NHS Improvement plan
Capability as well as capacity
The NHS Improvement plan
Learning and leadership
17 March 2005
Health and social care objectives
The NHS Plan
July 2000
Choosing Health – white paper
November 2004
NHS Improvement plan
Networks
Care in the community
Drivers, leavers and hooks
UK NHS Hospital Activity 2000-01• Average daily available beds per 1000 population:4.1
• Cases treated per available bed:43.1
• Total Accident & Emergency attendances: 17,534,00
NHS OVERSPENDS BY HALF A BILLION In Just One Year
Capital’s Trusts in Debt:
NHS Organisation: Forecast year end deficit:
University College London Hospitals
NHS Foundation Trust £32.5m
Hammersmith Hospitals NHS Trust £22m
St George’s Healthcare NHS Trust £12.5m
North West London Hospitals NHS Trust £11m
Hounslow Primary Care Trust £10.6m
Barking, Havering & Redbridge Hospitals
NHS Trust £10m
Queen Mary’s Sidcup NHS Trust £10m
NHS OVERSPENDS BY HALF A BILLION In Just One Year
Capital’s Trusts in Debt:
NHS Organisation: Forecast year end deficit:
Lewisham Hospitals NHS Trust £10m
Kensington & Chelsea Primary Care Trust £9.0m
Barnet & Chase Farm Hospitals NHS Trust £9.0m
North Middlesex Hospital NHS Trust £8.4m
Kingston Primary Care Trust £7.5m
Mayday Healthcare NHS Trust £6.8m
North Central London Strategic Health Authority £6.5m
Whipps Cross University NHS Trust £5.8m
Bexley Care Trust £5.7m
Royal Free Hospital NHS Trust £5.2m
Queen Elizabeth Hospital NHS Trust £5.0m
NHS OVERSPENDS BY HALF A BILLION In Just One Year
Capital’s Trusts in Debt:
NHS Organisation: Forecast year end deficit:
Waltham Forest Primary Care Trust £3.25m
King’s College Hospital NHS Trust £2.4m
Wandsworth Primary Care Trust £1.7m
Havering Primary Care Trust £1.6m
West Middlesex University NHS Trust £1.5m
Sutton & Merton Primary Care Trust £1.0m
Newham University NHS Trust £0.7m
The Whittington Hospital NHS Trust £0.7m
Royal National Orthopaedic NHS Trust £0.6m
NHS OVERSPENDS BY HALF A BILLION In Just One Year
Capital’s Trusts in Debt:
NHS Organisation: Forecast year end deficit:
Croydon Primary Care Trust £0.5m
Homerton University Hospital NHS Trust £0.5m
Greenwich Primary Care Trust £0.4m
Islington Primary Care Trust £0.4m
Moorfields Eye Hospital NHS Trust £0.3m
West London Mental Health NHS Trust £0.1m
Letter from Tony Blair to Patricia Hewitt Summer 2006
Primary Care
National Service framework
Points structure
Competition
PCT based commissioning to practice based commisioning
GPs retiring
Commissioning
Commissioning a patient-led NHS
Practice based commissioning (PBC)
Commissioning specialised services
The Health and social care system
Managing the system
Delivering primary care
Delivering social care
Integrated care
Organisation that work with DH
Health Objectives
10 High Impact changes (1-5)
Treat day surgery (rather than inpatient surgery) as the norm for elective surgery
Improve patient flow across the NHS system by improving access to key diagnostic tests
Manage variation in patient discharge, thereby reducing length of stay
Manage variation in the patient admission process
Avoid unnecessary follow-ups for patients and provide necessary follow-ups in the right care setting
10 High Impact changes (6-10)
Increase the reliability of performing therapeutic interventions through a Care Bundle approach
Apply a systematic approach to care for people with long-term conditions
Improve patient access by reducing the number of queues
Optimise patient flow through service bottlenecks using process templates
Redesign and extend roles in line with efficient patient pathways to attract and retain an effective workforce
The modern NHS – the vision
Payment by results
Patient choice
Care Bundles
Foundation hospitals
Plurality of delivery
Public private partnership
New technologies
Discharge strategies
Care in the communityPractice bases commissioning
Current state of the NHS
Managed Networks
Agenda for change
Technology transfer
What will private laboratories focus on ?
More automation
More reliance on molecular technology
Uneven playing field
Private companies interested in delivering pathology
- profitable tests
- High cost testsElectronic patient record
NHS in Crisis
Crisis or flux
Reducing beds
Surgical procedures out sourced
Slimmer more compact hospitals
Specialist tertiary care units
Care
Acute care
Community Care
Specialist care
Surgical capacity in NHS cut
Theatre lists reduced
Treatment centres
High street Primary care
ACAD
BCAD
Trust Mergers
Merging of Services
Paediatrics and Obstetrics
Rationalisation
Accident and Emergencies
Walk in Centres
Bed closures
Surgical capacity reduced
Surgeons made redundant
Weekly reports
Diagnostic tests used Pathology Radiology
Will infections go away?
Infections will still continue
HCAIs down?
Nosocomial infections reduced
Community infections rising
Elderly population rising
Bacteraemia slides?
Microbiology- Virology
Molecular suites
Chip technology
Array technology
Near patient testing and point of care testing
- pitfalls
- limitations
April 12, 2023
PbRPayment by results
PbR – the policy context
Chris Watson
Head of Payment by Results Development
pays NHS Trusts and other providers fairly and transparently for services delivered, while managing demand and risk
supports the introduction of patient choice by ensuring that diverse providers can be funded according to where patients choose to be treated
rewards efficiency and quality in providing services
helps match capacity to demand
refocuses discussion from disputes over price to the volume and mix of services that meet population need and the pathway of care for patients.
The move to a national tariff will be phased in over the next 5 years and our proposal is to do this in the following way:
2003/2004 transition using national tariff for each HRG
6 Surgical specialities
Move away from block contracts
SLA explicit links between funding and volume of services provided
No “block” agreements where funding is fixed regardless of the activity provided
SLA should set out clearly how risk will be handled
Prices determined locally rather than national tariff
Opthalmology, Cardiothoracic surgery, ENT, Trauma and orthopaedics, General surgery, Urology
2005 - 2006
The national tariff will be applied to all activity for which HRGs or other appropriate casemix measures are available. This means that almost all NHS Trust activity will be commissioned using Service Level Agreements that:
At specialty level, link funding to the planned volume of services to be provided and the national tariff for HRGs, adjusted for regional differences in costs;
Make clear how funding will be changed where the activity actually delivered, adjusted for casemix, differs from what was agreed;
Manage and share volume risk so as to encourage volume growth only where it is desirable for clinical and access reasons
Progress to full national tariff
Road Testing the PbR National Tariff for 2007/08 – 31 October 2006
http://www.dh.gov.uk/assetRoot/04/14/03/01/04140301.pdf
New Healthcare resource groups Version 4
Adult critical care
Emergency medicine
Pathology
Radiology
Chemotherapy
Radiotherapy
Specialist palliative care
Healthcare resource group
HRG 4 has been developed to support the governments payment by results initiative
It will be used to collect reference costs from 1 April 2007 and as the basis for national tariffs from April 2008
Payment by results
Key objective
Achieve fairer reimbursement by improving the sensitivity of the system to differences in casemix
Healthcare resource groups
Groups of clinically similar treatments and diagnoses which consume similar levelsof healthcare resource
Development is an on going process
Continually adapt to changes in clinical practice and the way services are configured
Sensitive to changes in care pathways that shift routine cases for treatment in community settings resulting in a more complex casemix being treated in hospitals
May –June 2006
HRG Version 4
Will form the basis of the tariff from 2008 and deliver improvements
Increased scope to include all aspects of Inpatient, Daycase and Outpatient activity
Better reflection of modern clinical practice
Consistency in design of all new and revised HRGs aligned across all specialities
Introduction of new HRGs for clinical specialities to accurately reflect patient care regardless of where it is given
Pathology
The efforts to create HRGs for Pathology have been in development for some years. With 1000s of tests to consider the cost-gathering exercise for Pathology HRGs is intricate.
It is envisaged that the HRGs will be setting-independent to cater for the increasing tendency toward supporting patient choice in delivering healthcare and availability of such services at GP practices.
A review of existing costings gathered during the lifetime of the project over the last few years is planned before pilot sites are recruited to test the conclusions. Pilot sites are expected to be recruited later this year.
The project consults with a clinical lead to ensure the delivered product fully respects the needs of pathologists.
Once developed the Pathology HRGs will be delivered to the Department of Health who will determine the tariffs for use within the PbR Programme.
The Pathology HRGs are expected to come into use in 2008.
HRG Labels - 1430
Nervous System Procedures and Disorders
Pain management
Eyes and periorbita procedures and diorders
Mouth Head Neck and Ears procedures and disorders
Thoracic procedures and disorders
Cardiac procedures
Digestive system surgery
Digestive system endoscopies
Gastroenterology Medicine
surgery
Hepatobiliary and pancreatic system endoscopies and radiological procedures
Hepatobiliary and pancreatic system disorders
Orthopaedic trauma procedures
Orthopaedic non-trauma procedures
Spinal surgery and disorders
Musculoskeletal disorders
Breast procedures and disorders
Hepatobiliary and pancreatic system Slin surgery
Skin disorders
Endocrine system disorders
Diabetic medicine
Metabolic disorders
Renal procedures and disorders
Urological procedures and disorders
Renal dialysis for chronic renal failure
Female reproductive system procedures
Assisted reproduction medicine
Obstetric medicine
Paediatric medicine
Vascular procedures and disorders
Radiological procedures
Interventional radiological procedures
Haematological disorders
Chemotherapy
Radiotherapy
Specialist palliative care
Multiple trauma
Emergency and urgent care
Rehabilitation
Immunology, infectious diseases etc
Treatment of mental health patients by non-mental health service providers
Genito-urinary medicine
Outpatients
Neonatal critical care
Paediatric critical care
Adult critical care
High cost drugs
Code of conduct
"We have seen with the first NHS foundation trusts how PbR provides powerful incentives for efficiency; but it is essential that the relationship between commissioner and provider is clearly defined and that both parties live up to their responsibilities. The Code will help ensure that happens and so we welcome it. We will continue to work with the Department of Health to ensure that the benefits from the introduction of PbR are maximised."William Moyes, Executive Chairman, Monitor,
PbRFinancial reformsDelivering the NHS Plan
NHS funding over 5 years – 7.4% real growth
Match European average by 2008
Use resources well – demonstrate value for money
Financial system transparent
Rules-based system for paying Trusts
Reward efficiency
Support patient choice and diversity
Support activity for sustainable waiting time reductions
Payment linked to activity and adjusted for casemix
Fair and consistent basis for hospital funding - rather than being reliant principally on historic budgets and the negotiating skills of individual managers
NHS Financial Flows, instead of being commissioned through block agreements as previously, hospitals (and other providers) will be paid for the activity that they undertake
Primary Care Trusts (PCTs) will commission:
the volume of activity required to deliver service priorities, adjusted for casemix (i.e. the mix of types of patients and/or treatment episodes)
from a plurality of providers
on the basis of a standard national price tariff, adjusted for regional variation in wages and other costs of service delivery
PbRSecondary uses Service (SUS)
Information technology has a key part to play in making the Payment by Results system run smoothly and efficiently. For 2006/07, NHS Connecting for Health have put in place a national reporting system for Payment by Results, which will eventually link directly with patient records. This system is part of the Secondary Users Service (SUS). It collects patient level activity information from providers and makes it available to commissioners. It is a national system, which will apply the tariff to providers’ activity information, calculate the payment due and notify each commissioner. For 2006/07, SUS outputs will be the definitive source of data for transactions under Payment by Results, replacing any local systems that may have been operating in 2005/06.
Key benefits of SUS:
ensuring that Payment by Results rules are applied accurately, consistently and transparently.
reducing bureaucracy, as NHS organisations no longer need separate information flows.
empowering commissioners. Their analysts are free to concentrate on analysing trends in the information rather than simply trying to apply the Payment by Results rules or check that their providers have applied them correctly.
enabling the Department to monitor the local impacts of Payment by Results at national level.
Healthcare Resource Groups (HRGs)
National intervention classifications
Under Payment by Results hospitals are paid according to the number and complexity of cases treated. The system therefore relies on patient-level data about activity in order to assign the appropriate tariff. The more detail that is captured about the patient’s treatment the greater potential for Payment by Results to differentiate different between routine and more complex cases and achieve fairer reimbursement.
For 2006/07 the underpinning classification system (known as OPCS-4.3) has been enhanced:
this is the first major update to the system in over 10 years;
it is co-ordinated with the ongoing development of casemix classifications (known as Healthcare Resource Groups (HRGs) which involves the input of over 250 clinicians representing Royal Colleges and professional bodies.
Commissioning, Casemix and Healthcare resource groups
The classification system has been expanded by nearly 25% (i.e. to date 1767 additional codes and 216 new categories) for improved coding accuracy. This gives a better representation of clinical reality and improved information for planning, monitoring and administration.
New inclusions under OPCS-4.3:
high-cost drugs
specialised services
diagnostic radiology
chemotherapy
interventional radiology
radiotherapy
Commissioning, Casemix and Healthcare resource groups
Commissioning, Casemix and Healthcare resource groups
VisionModernising pathology services
is built around the needs of patients and their clinicians, seeing services from their perspective
enables and empowers staff to work across traditional boundaries to deliver the highest quality care to all
offers patients greater choice in where, when and how they access pathology services
is integrated into wider service developments and improvements.
Impact on Microbiology servicesSmart efficient and modern
Compete for work
Business orientation
Shrinkage in the service
Agenda for change – Deskilling and re-skilling
Fewer commitments
Lean Mean – Six Sigma Small changes count
Improvements in Service
Smart working
Six Sigma
System, process and pathway analysis
Going further faster
Six Sigma
Methodology that focuses on removing variation from processes based on customer requirements
Structured approach to process improvement using 14 steps in 5 separate stages
Considered to have 3.4 defects per million opportunities
Six Sigma
Define: characterise customer-critical issues, initiate project
Measure: Characterise the current process
Analyse: Characterise the vital steps
Improve: Confirm problem areas and optimise
Control: sustain the gains
Tania King, Elizabeth Wolstencroft, Robert Mirsadeghi
Calderdale and Huddersfield and Royal Devon and Exeter
Tania King, Elizabeth Wolstencroft, Robert Mirsadeghi
Calderdale and Huddersfield and Royal Devon and Exeter
Tania King, Elizabeth Wolstencroft, Robert Mirsadeghi
Calderdale and Huddersfield and Royal Devon and Exeter
Tania King, Elizabeth Wolstencroft, Robert Mirsadeghi
Calderdale and Huddersfield and Royal Devon and Exeter
Tania King, Elizabeth Wolstencroft, Robert Mirsadeghi
Calderdale and Huddersfield and Royal Devon and Exeter
Tania King, Elizabeth Wolstencroft, Robert Mirsadeghi
Calderdale and Huddersfield and Royal Devon and Exeter
Quality – competing with private companies
Cost cutter
Lidl
Asda
Morrisons
Tesco
Sainsbury
Add value
Infection Services
- University College
- St Thomas
Other pathology specialities
Automation
Haematology Biochemistry Serology Virology Immunology
Microbiology
Workload demand
Do we really need to do this test
What difference will it make to the patient care
Virology
Mycology
Parasitology
Patient focused service
Patient centred care
Patient centred microbiology
More molecular technology
Some laboratories limiting tests
Urine microscopy
In patient stools – 3 day limit
What is required immediately?
What is required immediately?
What is required in a 2 - 3 yr period?
What is required in a 5 -10 yr plan?
How will this be delivered?
24 hour working?
Service modifications?
New technologies in Blood cultures
32 organism chip
Antigen based testing – helicobacter faecal antigen
Staffing
Staff specialisation
Staff deskilling & multiskilling
Add staffing curve
Different areas
Standard benches
Blood culture & CSF
Stool bench
STI bench
Wound bench
Respiratory bench
32 panel chips
Multiplex & molecular
Chlamydia & GC by PCR
MRSA PCR
Multiplex molecular PCRs
What do we need to do?
Lean mean machine
Strive ahead with changes and face the competition
Safeguards in place
Ensure quality systems in place
Added value – pre/post analytical - advice
Be patient focused
What is the best test for the patient?
Clinical adviceAreas to strengthen
Pre and post analytical advise in changing world
Reporting criteria
Clinical advice
Recording advice
Laboratory issues
Maintain standards and quality
Standards and quality for molecular bacteriology
When is Microscopy useful?
When is culture useful?
When is molecular useful?
How best to manage demand?
What levels of service should be offered?
Molecular technology
Bacteriology
Virology
Mycology Parasitology
Service – Fit for purpose
Patient focused
Clinical focused
Rapid diagnosis – influencing patient care – immediate
How should molecular services be used in bacteriology?
MRSA – PCR
rapid – but what to do with result – Care pathways
Chlamydia & GC PCR
Not rapid enough – can this be attached to the clinic
Group B strep PCR
Molecular testing
ILS - distributor
Cebheid
Smart cycler & Gene expert
Both real time PCR
HSV, Bordetella, enterovirus
Norovirus, Flu a & b , RSV, Mycoplasma, GBS, MRSA, SA, mec a
Decide what is suitable?
Open up to do lots of tests?
Real time PCR - gastroenterology
Norovirus PCR – being used in some diagnostic laboratories already – hospital outbreaks
Need Multiplex PCR for Stools
salmonella, shigella, campylobacter, E Coli O157,
Norovirus, Rotavirus, adenovirus
Helicobacter
Neurological PCR – HSV, VZV, EBV, CMV
Respiratory viruses – Multiplex 9 viruses
Real time PCR - neurological
Neurological PCR
– HSV, VZV, EBV, CMV
Meningococcal
Streptococcus pneumoniae
Group B Streptococcus
Respiratory viruses – Multiplex 9 viruses
Real time PCR - respiratory
Respiratory viruses
– Multiplex 9 viruses
Streptococcus pneumoniae
Haemophilus influenzae
Mycoplasma pneumoniae
Legionella
Staphylococcus aureus
(MC)
"Up to 70 per cent of all patient diagnoses depend on pathology but the importance of pathology services to patient care are too often underestimated. The NHS spends £1.5 billion a year on pathology and it is important that we take advantage of the advances made in pathology and improve efficieny. The independent review will put pathology services back in the centre stage and provide renewed vigour to the modernisation programme. Lord Carter of Coles will be leading the review and will be supported by two further members. Professor Chris Price will provide the professional pathology services expertise from his work in the public and private sectors. Marcus Robinson will provide a commercial perspective.“
Lord Warner 2 November 2005
"Up to 70 per cent of all patient diagnoses depend on pathology but the importance of pathology services to patient care are too often underestimated. The NHS spends £1.5 billion a year on pathology and it is important that we take advantage of the advances made in pathology and improve efficieny. The independent review will put pathology services back in the centre stage and provide renewed vigour to the modernisation programme. Lord Carter of Coles will be leading the review and will be supported by two further members. Professor Chris Price will provide the professional pathology services expertise from his work in the public and private sectors. Marcus Robinson will provide a commercial perspective.“
Lord Warner 2 November 2005
Lord Warner of Brockley
Minnister for State for reform
The Review Panel will be chaired by Lord Carter of Coles, who has a wide experience of chairing independent reviews, including; the Commonwealth Games 2002; English National Stadium; Review of Payroll Services; Review of Court Estate; Review of Offender Services, and the Review of the Procurement of Legal Aid.
Chris Price has expertise in pathology technology and evidence based outcomes and is currently the President of the Association of Clinical Biochemists and Vice President for Outcomes Research in Bayer Diagnostics. His previous roles include Cirector of Pathology at Barts and the Royal London Hospital.
Marcus Robinson has worked in a number of industries (including Financial Services, Automotive and Travel), but has concentrated on Government for the last 7 years. His areas of expertise are Finance and Performance Management, Customer Relationship Management and outsourcing. He is a Partner in Accenture Government Services.
The Review Panel’s remit is: ‘to advise Ministers, in the context of current resource constraints, on the timeliness, reliability , capacity and efficiency of current pathology services in England, benchmarked against international standards and the feasibility of and benefits arising from wide-scale service reconfiguration, innovation and modernisation and involvement of the independent sector.’
The review panel is expected to make recommendations to Ministers in spring 2006.
Derbyshire Children’s HospitalSouthern Derbyshire Acute Hospitals NHS Trust
Churchill Hospital, Radiotherapy SimulatorOxford Radcliffe Hospitals NHS Trust
Hammersmith Bridge Road SurgeryHammersmith and Fulham PCT
Neptune Health ParkTipton
GP surgery, pharmacy, optician, community health services, social and community centre and Café, and citizen advice centre
Hove Polyclinic - Hove
30 St Mary AxeDelivering excellence in the Hospital Building Programme
Sevenacres Acute Mental HealthIsle of Wight Healthcare NHS Trust
Datent Valley Hospital Dartford and Gravesham NHS Trust
Gloucestershire Royal Hospital Arts Project- Education CentreGloucestershire Hospitals NHS Trust
April 12, 2023
Thank you for listening
BBC, Times, DH, Websites